Balaxi Pharmaceuticals P/B Ratio
Balaxi Pharmaceuticals (BALAXI) P/B ratio is 0.51 (Low), book value per share ₹226.36 — Low - Trading below book value, may indicate undervaluation. Explore BALAXI fundamental worth to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
BALAXI P/B Ratio — Valuation Insights & Book Value Analysis
Balaxi Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 0.51 (Low). For live price, earnings yield and the full fundamental profile, see Balaxi Pharmaceuticals share price screener.
- Stock appears undervalued with PB of 0.51, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Trading at premium to sector average PB of 0.0
Balaxi Pharmaceuticals P/B Ratio Historical Trend
BALAXI annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read BALAXI dividend payout details for the complete payout history and dividend yield track record.
BALAXI Historical P/B Ratio — Book Value Per Share & Year-End Price
Balaxi Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.1 | ₹226.36 | ₹23.55 | ₹249 | Low |
| 2025 | 0.13 | ₹210.91 | ₹26.87 | ₹232 | Low |
| 2024 | 0.4 | ₹182.73 | ₹72.31 | ₹201 | Low |
| 2023 | 0.47 | ₹183.0 | ₹86.45 | ₹183 | Low |
| 2022 | 1.07 | ₹113.0 | ₹121.45 | ₹113 | Moderate |
BALAXI vs Healthcare Peers — P/B Ratio Comparison
Balaxi Pharmaceuticals P/B 0.51 vs Healthcare average 0.0, median 0.67 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |